Weight Research / 19.12.2024

ozempic-safety.jpg In recent years, Ozempic has become a cultural phenomenon, capturing headlines and transforming conversations about weight loss and diabetes management. What are the possible side effects of Ozempic? This question looms large as the medication continues to gain popularity among celebrities, social media influencers, and individuals struggling with weight management. Originally developed as a treatment for type 2 diabetes, Ozempic (semaglutide) has emerged as a powerful weight loss solution, sparking both excitement and concern within medical and public circles. The drug's rapid rise to prominence has created a complex narrative of hope, skepticism, and potential medical breakthrough. The medication belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking a hormone that targets areas of the brain involved in appetite regulation. By slowing down gastric emptying and reducing hunger, Ozempic helps patients consume fewer calories and lose significant amounts of weight. Clinical studies have demonstrated remarkable results, with patients experiencing substantial weight loss and improved metabolic health markers that extend far beyond traditional weight management approaches. The precision of its metabolic intervention has captured the attention of endocrinologists and weight management specialists worldwide. (more…)
Author Interviews, Diabetes, Kidney Disease, Nature, Semaglutide / 31.10.2024

MedicalResearch.com Interview on publication of: Prof. dr. H.J. (Hiddo) Lambers Heerspink Clinical Pharmacologist Faculty of Medical Sciences University of Groningen MedicalResearch.com: What is the background for this study? What are the main findings? Response: The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. The amount of protein in their urine decreased, as did the degree of inflammation of their kidneys and their blood pressure. Hiddo L. Heerspink got the idea for this study at the beginning of the corona pandemic. Earlier, he had discovered that another class of drugs against diabetes-2, the so-called SGLT2 inhibitors also appeared to work well for patients with chronic kidney damage without diabetes. He therefore wanted to investigate whether semaglutide would also work positively for patients with chronic kidney disease and obesity. (more…)
Semaglutide, Weight Research / 19.10.2024

In recent years, injectable weight loss medications have surged in popularity, becoming a preferred choice for individuals seeking effective and sustainable weight management solutions. This trend is driven by advancements in medical science, increased awareness of obesity-related health risks, and the convenience offered by online healthcare platforms. Among the various options available, medications like semaglutide and tirzepatide have gained significant attention for their efficacy in promoting weight loss.

Understanding Injectable Weight Loss Medications

Injectable weight loss medications are typically prescribed for individuals struggling with obesity or those who have not achieved desired weight loss results through diet and exercise alone. These medications work by targeting specific hormones and receptors in the body that regulate appetite, metabolism, and fat storage. Unlike oral weight loss pills, injectables often provide more consistent and potent effects, making them a viable option for long-term weight management. (more…)